Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Recruiting in Palo Alto (17 mi)

+7 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Hummingbird Diagnostics

No Placebo Group

Trial Summary

What is the purpose of this trial?

2,000 individuals, aged 50-80 who have received a lung-RADS category 3 or 4 result on a LDCT screening study and who are scheduled for follow-up diagnostic imaging study, biopsy, clinical consultation or surgical appointment at one of the participating hospitals.

Eligibility Criteria

Inclusion Criteria

You are a male or female aged between 50 and 80 years.

You have been identified to have a lung RADS category 3 or 4 result on an LDCT screening exam and are referred for further testing related to potential lung cancer.

You have recently undergone a LD-CT screening exam and are willing to provide blood samples within the last 90 days.

See 2 more